USMJ Confirms $20 Million Marijuana and CBD Sales Growth Plan

Rhea-AI Summary

North American Cannabis Holdings, Inc. (OTC Pink: USMJ) has confirmed plans to enhance its eCommerce business with an additional $20 million in sales. CEO Steven Rash outlined these growth strategies in a recent shareholder update. The company emphasizes its commitment to improving consumer wellness through cannabis, operating USMJ.com for ongoing product development. Potential risks include competition and the need for new contracts, as acknowledged in the disclaimer regarding forward-looking statements.

Positive

• Plans to add $20 million in sales to growing eCommerce business.
• Focus on improving consumer wellness through cannabis.

Negative

• Risks include competitive pressure and potential contract failures.

Dallas, Texas, April 05, 2022 (GLOBE NEWSWIRE) -- North American Cannabis Holdings, Inc. (OTC Pink: USMJ) today confirmed plans for adding $20 million in sales on top of the company’s growing sales from its expanding eCommerce business.  The company published a shareholder update last week with details on the company’s plans in a shareholder letter from CEO Steven Rash.

Learn more:

USMJ Details $20 Million Marijuana and CBD Sales Growth Plan In Shareholder Update

USMJ is founded on the core belief that cannabis makes people's lives better. Cannabis can fight disease, improve wellness and do so in an environmentally sustainable manner. North American Cannabis Holdings is dedicated to finding the best possible applications for cannabis to serve consumers. The Company operates USMJ.com and is dedicated to Ongoing Cannabis Consumer Product Development that it can incubate into Future Spin-offs.

Visit the company’s ecommerce site now and bookmark the site to watch for more coming announcements and updates: www.USMJ.com

Contact:
USMJ
Steven Rash
info@aciconglomerated.com
+1 (800) 861-1350

Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that Alkame will achieve significant sales, the failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

FAQ

What are USMJ's plans for increasing sales?

USMJ plans to add $20 million in sales through its expanding eCommerce business.

When was the shareholder update released by USMJ?

The shareholder update was published last week prior to April 5, 2022.

What does USMJ focus on in its business operations?

USMJ focuses on cannabis consumer product development and improving wellness.

What risks are associated with USMJ's future plans?

Risks include competition, liquidity issues, and failure to secure new contracts.

What is the stock symbol for North American Cannabis Holdings?

The stock symbol for North American Cannabis Holdings is USMJ.